Showing 1,341 - 1,360 results of 10,572 for search '"tumors"', query time: 0.09s Refine Results
  1. 1341

    Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer by Lukas Klein, Mengyu Tu, Niklas Krebs, Laura Urbach, Daniela Grimm, Muhammad Umair Latif, Frederike Penz, Anna Blandau, Xueyan Wu, Rebecca Diya Samuel, Stefan Küffer, Florian Wegwitz, Nathan Chan, Kazeera Aliar, Foram Vyas, Uday Kishore, Elisabeth Hessmann, Andreas Trumpp, Elisa Espinet, Argyris Papantonis, Rama Khokha, Volker Ellenrieder, Barbara T. Grünwald, Shiv K. Singh

    Published 2025-01-01
    “…ATAC-, ChIP-, and RNA-seq analyses reveal that JUNB/AP1- and HDAC-mediated epigenetic programs repress pro-inflammatory signatures in tumor cells, antagonizing cJUN/AP1 signaling, favoring a therapy-responsive classical neoplastic state. …”
    Get full text
    Article
  2. 1342

    LAMB1 promotes proliferation and metastasis in nasopharyngeal carcinoma and shapes the immune-suppressive tumor microenvironment by Enzi Feng, Xinyu Yang, Jie Yang, Qianqian Qu, Xiaojiang Li

    Published 2025-03-01
    “…But at low level of fibroblasts, LAMB1 directly suppressed immune response. Tumors with high LAMB1 level had weak responses to immunotherapy. …”
    Get full text
    Article
  3. 1343
  4. 1344
  5. 1345

    Pilomatrixoma of the parotid region: A benign tumor mimicking metastatic cutaneous squamous cell carcinoma by Nikita Grieder, MD, Marcella Pucci, MD, Claudio De Vito, MD, PhD, Yan Monnier, MD, PhD, Nicolas Dulguerov, MD, Maxime Mermod, MD, PhD

    Published 2025-04-01
    “…Head and neck tumors in adults present a broad differential diagnosis, particularly when considering malignant neoplasms that require prompt diagnosis and intervention. …”
    Get full text
    Article
  6. 1346

    Effects of RARα ligand binding domain mutations on breast fibroepithelial tumor function and signaling by Xi Xiao Huang, Ley Moy Ng, Po-Hsien Lee, Peiyong Guan, Mun Juinn Chow, Aisyah Binte Mohamed Bashir, Meina Lau, Kenric Yi Shu Tan, Zhimei Li, Jason Yongsheng Chan, Jing Han Hong, Sheng Rong Ng, Tun Kiat Ko, Hong Lee Heng, Hsiang Ling Teo, Daniela Rhodes, Patrick Tan, Puay Hoon Tan, Donald P. McDonnell, Bin Tean Teh

    Published 2025-01-01
    “…Abstract Point mutations in the ligand binding domain of retinoic acid receptor alpha (RARα) are linked to breast fibroepithelial tumor development, but their role in solid tumorigenesis is unclear. …”
    Get full text
    Article
  7. 1347
  8. 1348
  9. 1349
  10. 1350

    False Positive Radioiodinated Metaiodobenzylguanidine (123I-MIBG) Uptake in Undifferentiated Adrenal Malignant Tumor by Hee Soo Jung, Seok Jun Moon, Yun Mi Kim, Hye Rim Kang, Seok Mo Lee, Soo Jin Jung, Seok Jin Choi, Tae Kyoon Kim, Min Jeong Kwon, Jeong Hyun Park, Soon Hee Lee

    Published 2015-01-01
    “…A final diagnosis of undifferentiated adrenal malignant tumor was rendered, instead of histologically malignant pheochromocytoma, despite the uptake of 123I-MIBG demonstrated by scintigraphy.…”
    Get full text
    Article
  11. 1351

    Knockout or inhibition of DHPS suppresses ovarian tumor growth and metastasis by attenuating the TGFβ pathway by Guannan Zhao, Xinxin Zhao, Ziping Liu, Baojin Wang, Peixin Dong, Hidemichi Watari, Lawrence M. Pfeffer, Gabor Tigyi, Wenjing Zhang, Junming Yue

    Published 2025-01-01
    “…DHPS regulates the translation initiation factor EIF5A, and EIF5A2 knockout inhibits OC tumor growth and metastasis by blocking the epithelial-to-mesenchymal transition (EMT) and the TGFβ pathway. …”
    Get full text
    Article
  12. 1352
  13. 1353
  14. 1354

    Molecule interacting with CasL-2 enhances tumor progression and alters radiosensitivity in cervical cancer by Yun Teng, Hongmei Zhao, Guoqing Xue, Guohui Zhang, Yanbin Huang, Wei Guo, Kun Zou, Lijuan Zou

    Published 2025-01-01
    “…Conclusion MICAL2 plays a critical role in tumor progression and radiotherapy resistance in cervical cancer. …”
    Get full text
    Article
  15. 1355

    Comparison of Epirubicin-Iodized Oil Suspension and Emulsion for Transcatheter Arterial Chemoembolization in VX2 Tumor by Tatsuo Ueda, Satoru Murata, Takahiko Mine, Shiro Onozawa, Munehiko Onda, Zenya Naito, Yasuo Amano, Shinichiro Kumita

    Published 2012-01-01
    “…Changes in plasma epirubicin concentration were compared over 24 h immediately after treatment, and enhanced ultrasonographic and histopathological analysis subsequently conducted 7 days after treatment to determine the growth ratio and proportion of viable tumor cells. The growth ratio and proportion of viable tumor cells were found to be significantly lower in the suspension group than in the emulsion group while the plasma epirubicin concentration was found to be significantly higher in the suspension group than in the emulsion group. …”
    Get full text
    Article
  16. 1356

    Tumores de las glándulas salivales mayores. Estudio de una serie de casos by Yordany Boza Mejías, Julio Romero Rodríguez, Enrique Pérez Abreus, Raúl López Fernández, Arelis Duménico Soler, Teresita Barrios

    Published 2012-09-01
    “…<strong>Fundamento:</strong> el estudio de las neoplasias de las glándulas salivales constituye uno de los problemas más complejos de la enfermedad tumoral de la cabeza y el cuello. <strong><br />Objetivo: </strong>determinar el comportamiento de los tumores de las glándulas salivales mayores. …”
    Get full text
    Article
  17. 1357
  18. 1358
  19. 1359

    Biopsy location and tumor-associated macrophages in predicting malignant glioma recurrence using an in-silico model by Pejman Shojaee, Edwin Weinholtz, Nadine S. Schaadt, Friedrich Feuerhake, Haralampos Hatzikirou

    Published 2025-01-01
    “…In conclusion, the results show that localized biopsies provided more information about tumor behavior, especially at the interface of tumor and normal tissue (Edge).…”
    Get full text
    Article
  20. 1360

    A Rare Case of Histiocytic Sarcoma Secondary to Gastrointestinal Stromal Tumor in the Stomach: Transdifferentiation or Synchronicity? by Jiankun Tong, Jean Luo, Pierre F. Saldinger, William H. Rodgers

    Published 2021-01-01
    “…Here, we report a 68-year-old female who developed histiocytic sarcoma following chemotherapy with imatinib (Gleevec) for gastrointestinal stromal tumor. Possible mechanisms of transdifferentiation from gastrointestinal stromal tumor to histiocytic sarcoma are discussed based on the features of our case and other two similar cases in the literature.…”
    Get full text
    Article